Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

NCT01666717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 204

Last updated 2012-08-17

No results posted yet for this study

Summary

The purpose of the study is to evaluate fecal metabolites profiles of Inflammatory Bowel Disease(IBD) patients versus healthy controls (HC).

Conditions

  • Inflammatory Bowel Diseases

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Completion
2012-05-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01666717 on ClinicalTrials.gov